(Total Views: 598)
Posted On: 09/12/2020 4:26:49 PM
Post# of 148984
IMMU's Trodelvy has already completed phase 3 and has been approved by the FDA, I think.
Leronlimab has some excellent initial data in triple negative breast cancer but the reduction in circulating tumor cells needs to be validated by other clinical efficacy markers.
Leronlimab has some excellent initial data in triple negative breast cancer but the reduction in circulating tumor cells needs to be validated by other clinical efficacy markers.
(1)
(0)Scroll down for more posts ▼
